Log in to your IBTimes Account

close
ID
Password

Asterand to acquire BioSeek



18 November 2009 @ 09:11 am BST

Asterand has signed an agreement to acquire BioSeek, a pioneer in the application of predictive human biology to drug discovery through its human primary cell based disease models.

The deal is subject to Asterand shareholders' approval. Asterand said it achieved revenue of 9.1m in the nine months to the end of September compared with 8m last year - excluding the licensing payments from Allergan.

Revenues for the same period last year also contained 1.1m relating to a one year contract that ended in December 2008.

The company said it continued to control its expenditures while maintaining strong cash resources of 5.2m (30 June: 5.8m).

Story provided by Business Financial Newswire

© 2009 BFNNews.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


advertisement
More Markets
Former Victoria chairman Alexander Anton has resigned from the board with immediate effect.Anton stepped down as chairman of the carpet firm at the end o...
Total inventories of US wholesalers were $383.6bn at the end of December.This was 0.8% down from the revised November level and down 10.2% from a year ag...
The aggregate funding position of final salary schemes worsened last month with overall deficit of the 7,400 defined benefit schemes widening to £51.9m f...

advertisement
 
 
IBTimes © 2010 The IBTimes Company Ltd. All Rights Reserved. Partners